ImOverweight - FACEIT level 8, 1,700 ELO

Serbia
On FACEIT since 2023 150 matches tracked 103 matches in 30 days
Last updated:

ImOverweight at a glance

Level 8 1,700 ELO best map Anubis (71%)
Level 8

Last 20 matches compared with 2,994 players in this group: K/R, ADR and win rate above average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 40%
0.98
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.30 ConsistencyShare of matches with a rating of 0.90 or higher. 55%
K/R
0.74
better than 57% of players
Level 8 avg: 0.72
Last 12 months
ADR
79.7
better than 50% of players
Level 8 avg: 79.2
Last 12 months
Win rate
50%
better than 49% of players
Level 8 avg: 48%
Last 12 months

Facts

51 ELO Next goal ELO to level 9
5 Comebacks last 90 days
3 W · 2 L Overtime in overtime
Dust 2 Favorite map 36 of 150 matches
Anubis 71% Map pool tip weakest: Mirage 34%
1 Zeus kill Rare kills 5 knife kills
On Saturdays Playing times most active
On Fridays Best time 67% win rate vs. 51%
FormMapsTiming

51 ELO away from level 9. 5 wins after trailing at halftime (last 90 days). 5 matches in overtime, 3 of them won (last 90 days). Most played: Dust 2 (36 of 150 matches). Strongest map: Anubis (71% win rate, 14 matches). Weakest: Mirage (34%, 35 matches). 1 Zeus kill and 5 knife kills (last 90 days). Plays most on Saturdays (based on 150 matches). Best results on Fridays: 67% win rate vs. 51% overall (21 matches).

About ImOverweight

ImOverweight plays CS2 on FACEIT level 8 with 1,700 ELO. The stats cover 150 matches. The strongest map is Anubis with a 71% win rate in 14 matches. Most played: Dust 2 with 36 matches and a 44% win rate. Biggest strength: Headshot rate at 65%, better than 99% of level 8 players. ImOverweight won 5 matches after trailing at halftime (last 90 days). Last 20 matches: 10 wins, 10 losses, -8 ELO. Previously known as Meisterlay. ImOverweight does best on Fridays: 67% win rate in 21 matches.